Sunday, October 5, 2008

Emergent Biosolutions wins $364M anthrax vaccine award

This week DHHS contracted to buy 14.5 million more doses of EBS' anthrax vaccine. It has already purchased about 25 million doses for a civilian stockpile. This supply may be where the vaccine for first responders will come from. GAO reported in 2007 on the large losses DHHS will incur when the anthrax vaccine outdates; vaccinating first responders may be a way of rotating vaccine stocks.

1 comment:

Anonymous said...

Are there any links within Emergent Biosolutions, Gilead, the American Enterprise Institute, Donald Rumsfeld and Philip Zack ? It would be interesting!!